Studies have shown that in T2D patients, the diminished insulin-to-glucagon ratio, instigated by the attenuation of plasma glucose levels through the administration of SGLTis, can redirect energy metabolism towards increased utilization of fat, augmented fatty acid oxidation, and heightened ketogenesis [53]. Here, INS is linked to type 2 diabetes mellitus.